Evotec SE EVO
NASDAQ EVO
$1.92 -0.06 (-3.02%)
At close: Aug 20, 2026 · 2:33 PM UTC

Evotec SE (EVO) Selling, General & Administrative (2009 - 2025)

Evotec SE (EVO) Selling, General & Administrative (2009 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Haleon 43.86 Bn 42.90 Bn - -
2 Teva Pharmaceutical Industries 43.19 Bn 39.54 Bn 2.15 Bn 317.00 Mn
3 Zoetis 31.46 Bn 29.79 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.57 Bn 22.77 Bn 5.10 Bn -1.80 Bn
5 United Therapeutics 22.15 Bn 19.49 Bn 683.80 Mn 206.70 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 1.13 Bn
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn 439.70 Mn
8 Elanco Animal Health 11.71 Bn 11.18 Bn 798.00 Mn 449.00 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn - -
10 Evotec SE 681.90 Mn 681.42 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 204.85 Mn
Sep 30, 2025 -6,142.22
Dec 31, 2024 17.23 Mn
Sep 30, 2024 -3,798.74
Dec 31, 2023 182.54 Mn
Sep 30, 2023 7,631.02
Jun 30, 2023 -49,664.75
Dec 31, 2022 159.35 Mn
Sep 30, 2022 337.77
Jun 30, 2022 -38,232.64
Mar 31, 2022 -35,427.71
Dec 31, 2021 120.62 Mn
Sep 30, 2021 331.38
Jun 30, 2021 -1,324.70
Mar 31, 2021 -25,564.97
Dec 31, 2020 5.92 Mn
Sep 30, 2020 1,515.00
Dec 31, 2019 73.53 Mn
Sep 30, 2010 1,794.87
Jun 30, 2010 1,246.79